Literature DB >> 15562504

Phenotype of cerebellar glutamatergic neurons is altered in stargazer mutant mice lacking brain-derived neurotrophic factor mRNA expression.

Christine A Richardson1, Beulah Leitch.   

Abstract

Brain-derived neurotrophic factor (BDNF) influences neuronal survival, differentiation, and maturation. More recently, its role in synapse formation and plasticity has also emerged. In the cerebellum of the spontaneous recessive mutant mouse stargazer (stg) there is a specific and pronounced deficit in BDNF mRNA expression. BDNF protein levels in the cerebellum as a whole are reduced by 70%, while in the granule cells (GCs) there is a selective and near total reduction in BDNF mRNA expression. Recently, we published data demonstrating that inhibitory neurons in the cerebella of stgs have significantly reduced levels (approximately 50%) of gamma-aminobutyric acid (GABA) and fewer, smaller inhibitory synapses compared to wildtype (WT) controls. Our current investigations indicate that the stargazer mutation has an even more pronounced effect on the phenotype of glutamatergic neurons in the cerebellum. There is a profound decrease in the levels of glutamate-immunoreactivity (up to 77%) in stg compared to WT controls. The distribution profile of presynaptic vesicles is also markedly different: stgs have proportionally fewer docked vesicles and fewer vesicles located adjacent to the active zone ready to dock than WTs. Furthermore, the thickness of the postsynaptic density (PSD) at mossy fiber-granule cell (MF-GC) and parallel fiber-Purkinje cell (PF-PC) synapses is severely reduced (up to 33% less than WT controls). The number and length of excitatory synapses, however, appear to be relatively unchanged. It is possible that at least some of theses changes in phenotype are directly attributable to the lack of BDNF in the cerebellum of the stg mutant. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15562504     DOI: 10.1002/cne.20386

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  13 in total

Review 1.  Activity-dependent modulation of inhibition in Purkinje cells by TrkB ligands.

Authors:  Rosemarie Drake-Baumann
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

2.  Characterization of on-target adverse events caused by TRK inhibitor therapy.

Authors:  D Liu; J Flory; A Lin; M Offin; C J Falcon; Y R Murciano-Goroff; E Rosen; R Guo; E Basu; B T Li; J J Harding; G Iyer; K Jhaveri; M M Gounder; N N Shukla; S S Roberts; J Glade-Bender; L Kaplanis; A Schram; D M Hyman; A Drilon
Journal:  Ann Oncol       Date:  2020-05-15       Impact factor: 32.976

3.  Stargazer--a mouse to seize!

Authors:  Verity A Letts
Journal:  Epilepsy Curr       Date:  2005 Sep-Oct       Impact factor: 7.500

4.  The alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor trafficking regulator "stargazin" is related to the claudin family of proteins by Its ability to mediate cell-cell adhesion.

Authors:  Maureen G Price; Caleb F Davis; Fang Deng; Daniel L Burgess
Journal:  J Biol Chem       Date:  2005-03-10       Impact factor: 5.157

5.  Stargazin (TARP gamma-2) is required for compartment-specific AMPA receptor trafficking and synaptic plasticity in cerebellar stellate cells.

Authors:  Alexander C Jackson; Roger A Nicoll
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 6.  TRKing down an old oncogene in a new era of targeted therapy.

Authors:  Aria Vaishnavi; Anh T Le; Robert C Doebele
Journal:  Cancer Discov       Date:  2014-12-19       Impact factor: 39.397

7.  Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Jill M Weimer; Jared W Benedict; Amanda L Getty; Charlie C Pontikis; Ming J Lim; Jonathan D Cooper; David A Pearce
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

Review 8.  NTRK fusion-positive cancers and TRK inhibitor therapy.

Authors:  Emiliano Cocco; Maurizio Scaltriti; Alexander Drilon
Journal:  Nat Rev Clin Oncol       Date:  2018-12       Impact factor: 66.675

Review 9.  TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults.

Authors:  Guilherme Harada; Alexander Drilon
Journal:  Cancer Genet       Date:  2022-03-16

10.  Channel properties reveal differential expression of TARPed and TARPless AMPARs in stargazer neurons.

Authors:  Cécile Bats; David Soto; Dorota Studniarczyk; Mark Farrant; Stuart G Cull-Candy
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.